
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
Before leaving office, California Governor Gray Davis signed new laws to boost controversial stem cell research seen as key to new medical advances.